Lantheus Medical Imaging said it will replace its chief financial officer (CFO), effective August 9.
Current CFO Jeffrey Young is leaving the contrast agent developer to take a new position, and John Golubieski has been appointed as interim CFO. Young will work with Golubieski to ensure a smooth transition, said Lantheus, which praised Young's contributions over five years at the firm.
Golubieski brings extensive financial and business leadership experience to the company, most recently serving as CFO at Fougera Pharmaceuticals, Lantheus said.
